Benitah NR, Arroyo JG. Pseudophakic cystoid macular edema. Int Ophthalmol Clin. 2010. 50(1):139-53. [QxMD MEDLINE Link].
Henderson BA, Kim JY, Ament CS, Ferrufino-Ponce ZK, Grabowska A, Cremers SL. Clinical pseudophakic cystoid macular edema. Risk factors for development and duration after treatment. J Cataract Refract Surg. 2007 Sep. 33(9):1550-8. [QxMD MEDLINE Link].
Copete S, Martí-Rodrigo P, Muñiz-Vidal R, Pastor-Idoate S, Rigo J, Figueroa MS, et al. PREOPERATIVE VITREORETINAL INTERFACE ABNORMALITIES ON SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY AS RISK FACTOR FOR PSEUDOPHAKIC CYSTOID MACULAR EDEMA AFTER PHACOEMULSIFICATION. Retina. 2018 Aug 28. [QxMD MEDLINE Link].
Schaub F, Adler W, Enders P, Koenig MC, Koch KR, Cursiefen C, et al. Preexisting epiretinal membrane is associated with pseudophakic cystoid macular edema. Graefes Arch Clin Exp Ophthalmol. 2018 May. 256 (5):909-917. [QxMD MEDLINE Link].
Bélair ML, Kim SJ, Thorne JE, Dunn JP, Kedhar SR, Brown DM. Incidence of cystoid macular edema after cataract surgery in patients with and without uveitis using optical coherence tomography. Am J Ophthalmol. 2009 Jul. 148(1):128-35.e2. [QxMD MEDLINE Link].
Shelsta HN, Jampol LM. Pharmacologic therapy of pseudophakic cystoid macular edema: 2010 update. Retina. 2011 Jan. 31(1):4-12. [QxMD MEDLINE Link].
Hunter AA, Modjtahedi SP, Long K, Zawadzki R, Chin EK, Caspar JJ, et al. Improving visual outcomes by preserving outer retina morphology in eyes with resolved pseudophakic cystoid macular edema. J Cataract Refract Surg. 2014 Apr. 40(4):626-31. [QxMD MEDLINE Link].
Jiramongkolchai K, Lalezary M, Kim SJ. Influence of previous vitrectomy on incidence of macular oedema after cataract surgery in diabetic eyes. Br J Ophthalmol. 2011 Apr. 95(4):524-9. [QxMD MEDLINE Link].
Chu CJ, Johnston RL, Buscombe C, Sallam AB, Mohamed Q, Yang YC, et al. Risk Factors and Incidence of Macular Edema after Cataract Surgery: A Database Study of 81984 Eyes. Ophthalmology. 2016 Feb. 123 (2):316-23. [QxMD MEDLINE Link].
Daien V, Korobelnik JF, Delcourt C, Cougnard-Gregoire A, Delyfer MN, Bron AM, et al. French Medical-Administrative Database for Epidemiology and Safety in Ophthalmology (EPISAFE): The EPISAFE Collaboration Program in Cataract Surgery. Ophthalmic Res. 2017. 58 (2):67-73. [QxMD MEDLINE Link].
Yoon DH, Kang DJ, Kim MJ, Kim HK. New observation of microcystic macular edema as a mild form of cystoid macular lesions after standard phacoemulsification: Prevalence and risk factors. Medicine (Baltimore). 2018 Apr. 97 (15):e0355. [QxMD MEDLINE Link].
Panteleontidis V, Detorakis ET, Pallikaris IG, Tsilimbaris MK. Latanoprost-Dependent Cystoid Macular Edema Following Uncomplicated Cataract Surgery in Pseudoexfoliative Eyes. Ophthalmic Surg Lasers Imaging. 2010 Mar 9. 1-5. [QxMD MEDLINE Link].
Law SK, Kim E, Yu F, Caprioli J. Clinical cystoid macular edema after cataract surgery in glaucoma patients. J Glaucoma. 2010 Feb. 19(2):100-4. [QxMD MEDLINE Link].
Hunter A, Chin EK, Telander DG. Macular edema in the era of spectral-domain optical coherence tomography. Clin Ophthalmol. 2013. 7:2085-2089. [QxMD MEDLINE Link]. [Full Text].
Ahmadabadi HF, Mohammadi M, Beheshtnejad H, Mirshahi A. Effect of intravitreal triamcinolone acetonide injection on central macular thickness in diabetic patients having phacoemulsification. J Cataract Refract Surg. 2010 Jun. 36(6):917-22. [QxMD MEDLINE Link].
Thach AB, Dugel PU, Flindall RJ, Sipperley JO, Sneed SR. A comparison of retrobulbar versus sub-Tenon's corticosteroid therapy for cystoid macular edema refractory to topical medications. Ophthalmology. 1997 Dec. 104(12):2003-8. [QxMD MEDLINE Link].
Khurana RN, Palmer JD, Porco TC, Wieland MR. Dexamethasone intravitreal implant for pseudophakic cystoid macular edema in patients with diabetes. Ophthalmic Surg Lasers Imaging Retina. 2015 Jan. 46(1):56-61. [QxMD MEDLINE Link]. [Full Text].
Dang Y, Mu Y, Li L, Mu Y, Liu S, Zhang C, et al. Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients. Drug Des Devel Ther. 2014. 8:1441-9. [QxMD MEDLINE Link]. [Full Text].
Mayer WJ, Kurz S, Wolf A, Kook D, Kreutzer T, Kampik A, et al. Dexamethasone implant as an effective treatment option for macular edema due to Irvine-Gass syndrome. J Cataract Refract Surg. 2015 Sep. 41 (9):1954-61. [QxMD MEDLINE Link].
Sivaprasad S, Bunce C, Crosby-Nwaobi R. Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery. Cochrane Database Syst Rev. 2012 Feb 15. 2:CD004239. [QxMD MEDLINE Link].
Flach AJ, Jampol LM, Weinberg D, et al. Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine. Am J Ophthalmol. 1991 Nov 15. 112(5):514-9. [QxMD MEDLINE Link].
Gamache DA, Graff G, Brady MT, Spellman JM, Yanni JM. Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy. Inflammation. 2000 Aug. 24(4):357-70. [QxMD MEDLINE Link].
Sivaprasad S, Bunce C, Crosby-Nwaobi R. Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery. Cochrane Database Syst Rev. 2012 Feb 15. 2:CD004239. [QxMD MEDLINE Link].
Pepple KL, Nguyen MH, Pakzad-Vaezi K, Williamson K, Odell N, Lee C, et al. RESPONSE OF INFLAMMATORY CYSTOID MACULAR EDEMA TO TREATMENT USING ORAL ACETAZOLAMIDE. Retina. 2018 Jan 16. [QxMD MEDLINE Link].
Telander D, Hunter A, Hariprasad SM. The evolving paradigm for the treatment of diabetic macular edema. Ophthalmic Surg Lasers Imaging Retina. 2013 Jul-Aug. 44(4):324-8. [QxMD MEDLINE Link].
Spitzer MS, Ziemssen F, Yoeruek E, Petermeier K, Aisenbrey S, Szurman P. Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema. J Cataract Refract Surg. 2008 Jan. 34(1):70-5. [QxMD MEDLINE Link].
Arain MA, Muzaffar W, Farooq O, Azhar MN. Combined Intravitreal Triamcenolone Acetonide and Bevacizumab for Refractory Diabetic Macular Edema. J Coll Physicians Surg Pak. 2018 Aug. 28 (8):603-606. [QxMD MEDLINE Link].
Loewenstein A, Zur D. Postsurgical cystoid macular edema. Dev Ophthalmol. 2010. 47:148-59. [QxMD MEDLINE Link].
Pendergast SD, Margherio RR, Williams GA, Cox MS Jr. Vitrectomy for chronic pseudophakic cystoid macular edema. Am J Ophthalmol. 1999 Sep. 128(3):317-23. [QxMD MEDLINE Link].
Almeida DR, Johnson D, Hollands H, Smallman D, Baxter S, Eng KT. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. J Cataract Refract Surg. 2008 Jan. 34(1):64-9. [QxMD MEDLINE Link].
Campa C, Salsini G, Perri P. Comparison of the Efficacy of Dexamethasone, Nepafenac, and Bromfenac for Preventing Pseudophakic Cystoid Macular Edema: an Open-label, Prospective, Randomized Controlled Trial. Curr Eye Res. 2018 Mar. 43 (3):362-367. [QxMD MEDLINE Link].
Altintas O, Yuksel N, Karabas VL, Demirci G. Cystoid macular edema associated with latanoprost after uncomplicated cataract surgery. Eur J Ophthalmol. 2005 Jan-Feb. 15(1):158-61. [QxMD MEDLINE Link].
Arevalo JF, Garcia-Amaris RA, Roca JA, et al. Primary intravitreal bevacizumab for the management of pseudophakic cystoid macular edema: pilot study of the Pan-American Collaborative Retina Study Group. J Cataract Refract Surg. 2007 Dec. 33(12):2098-105. [QxMD MEDLINE Link].
Barone A, Prascina F, Russo V, et al. Successful treatment of pseudophakic cystoid macular edema with intravitreal bevacizumab. J Cataract Refract Surg. 2008 Jul. 34(7):1210-2. [QxMD MEDLINE Link].
Barone A, Russo V, Prascina F, Delle Noci N. Short-term safety and efficacy of intravitreal bevacizumab for pseudophakic cystoid macular edema. Retina. 2009 Jan. 29(1):33-7. [QxMD MEDLINE Link].
Flach AJ, Stegman RC, Graham J, Kruger LP. Prophylaxis of aphakic cystoid macular edema without corticosteroids. A paired-comparison, placebo-controlled double-masked study. Ophthalmology. 1990 Oct. 97(10):1253-8. [QxMD MEDLINE Link].
Fung WE. Vitrectomy for chronic aphakic cystoid macular edema. Results of a national, collaborative, prospective, randomized investigation. Ophthalmology. 1985 Aug. 92(8):1102-11. [QxMD MEDLINE Link].
Gamache DA, Graff G, Brady MT, Spellman JM, Yanni JM. Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy. Inflammation. 2000 Aug. 24(4):357-70. [QxMD MEDLINE Link].
Gass JD, Norton EW. Cystoid macular edema and papilledema following cataract extraction. A fluorescein fundoscopic and angiographic study. Arch Ophthalmol. 1966 Nov. 76(5):646-61. [QxMD MEDLINE Link].
Gass JD, Norton EW. Fluorescein studies of patients with macular edema and papilledema following cataract extraction. Trans Am Ophthalmol Soc. 1966. 64:232-49. [QxMD MEDLINE Link].
Gass JD, Norton EW. Follow-up study of cystoid macular edema following cataract extraction. Trans Am Acad Ophthalmol Otolaryngol. 1969 Jul-Aug. 73(4):665-82. [QxMD MEDLINE Link].
Harbour JW, Smiddy WE, Rubsamen PE, Murray TG, Davis JL, Flynn HW Jr. Pars plana vitrectomy for chronic pseudophakic cystoid macular edema. Am J Ophthalmol. 1995 Sep. 120(3):302-7. [QxMD MEDLINE Link].
Holekamp NM. Treatment of pseudophakic CME. Ocul Immunol Inflamm. 1998 Jun. 6(2):121-3. [QxMD MEDLINE Link].
Irvine SR. A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmol. 1953 May. 36(5):499-619. [QxMD MEDLINE Link].
Italian Diclofenac Study Group. Efficacy of diclofenac eyedrops in preventing postoperative inflammation and long-term cystoid macular edema. Italian Diclofenac Study Group. J Cataract Refract Surg. 1997 Oct. 23(8):1183-9. [QxMD MEDLINE Link].
Jampol LM. Pharmacologic therapy of aphakic cystoid macular edema. A review. Ophthalmology. 1982 Aug. 89(8):891-7. [QxMD MEDLINE Link].
Ke TL, Graff G, Spellman JM, Yanni JM. Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers. Inflammation. 2000 Aug. 24(4):371-84. [QxMD MEDLINE Link].
Lane SS, Modi SS, Lehmann RP, Holland EJ. Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery. J Cataract Refract Surg. 2007 Jan. 33(1):53-8. [QxMD MEDLINE Link].
McColgin AZ, Raizman MB. Efficacy of topical Voltaren in reducing the incidence of postoperative cystoid macular edema. Invest Ophthalmol Vis Sci. 1999. 40:S289.
Rao SK, Cheung N, Lam DS. Prophylaxis for pseudophakic cystoid macular oedema: a long way to go. Clin Experiment Ophthalmol. 2006 May-Jun. 34(4):295-6. [QxMD MEDLINE Link].
Ray S, D'Amico DJ. Pseudophakic cystoid macular edema. Semin Ophthalmol. 2002 Sep-Dec. 17(3-4):167-80. [QxMD MEDLINE Link].
Rho DS. Treatment of acute pseudophakic cystoid macular edema: Diclofenac versus ketorolac. J Cataract Refract Surg. 2003 Dec. 29(12):2378-84. [QxMD MEDLINE Link].
Rossetti L, Autelitano A. Cystoid macular edema following cataract surgery. Curr Opin Ophthalmol. 2000 Feb. 11(1):65-72. [QxMD MEDLINE Link].
Ruiz RS, Saatci OA. Visual outcome in pseudophakic eyes with clinical cystoid macular edema. Ophthalmic Surg. 1991 Apr. 22(4):190-3. [QxMD MEDLINE Link].
Sivaprasad S, Bunce C, Crosby-Nwaobi R. Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery. Cochrane Database Syst Rev. 2012 Feb 15. 2:CD004239. [QxMD MEDLINE Link].
Solomon LD. Efficacy of topical flurbiprofen and indomethacin in preventing pseudophakic cystoid macular edema. Flurbiprofen-CME Study Group I. J Cataract Refract Surg. 1995 Jan. 21(1):73-81. [QxMD MEDLINE Link].
Stark WJ Jr, Maumenee AE, Fagadau W, et al. Cystoid macular edema in pseudophakia. Surv Ophthalmol. 1984 May. 28 Suppl:442-51. [QxMD MEDLINE Link].
Telander DG, Sarraf D. Cystoid macular edema with docetaxel chemotherapy and the fluid retention syndrome. Semin Ophthalmol. 2007 Jul-Sep. 22(3):151-3. [QxMD MEDLINE Link].
Ursell PG, Spalton DJ, Whitcup SM, Nussenblatt RB. Cystoid macular edema after phacoemulsification: relationship to blood-aqueous barrier damage and visual acuity. J Cataract Refract Surg. 1999 Nov. 25(11):1492-7. [QxMD MEDLINE Link].
Warren KA, Fox JE. Topical nepafenac as an alternate treatment for cystoid macular edema in steroid responsive patients. Retina. 2008 Nov-Dec. 28(10):1427-34. [QxMD MEDLINE Link].
Wright PL, Wilkinson CP, Balyeat HD, Popham J, Reinke M. Angiographic cystoid macular edema after posterior chamber lens implantation. Arch Ophthalmol. 1988 Jun. 106(6):740-4. [QxMD MEDLINE Link].